The treatment of severe malaria.
In the SEAQUAMAT trial, parenteral artesunate was shown to be associated with a considerably lower mortality than quinine, and is now the recommended treatment for severe malaria in low-transmission areas and in the second and third trimesters of pregnancy. A trial is underway to establish its role...
मुख्य लेखकों: | Dondorp, A, Day, N |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
2007
|
समान संसाधन
-
The management of patients with severe malaria.
द्वारा: Day, N, और अन्य
प्रकाशित: (2007) -
The treatment of severe malaria
द्वारा: Dondorp, A
प्रकाशित: (2007) -
UK recommendations for severe malaria are worrying.
द्वारा: White, N, और अन्य
प्रकाशित: (2007) -
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.
द्वारा: Dondorp, A, और अन्य
प्रकाशित: (2005) -
Malaria treatment in the United States.
द्वारा: Hanson, J, और अन्य
प्रकाशित: (2007)